BioCentury
ARTICLE | Company News

HaptoGuard, University of Calgary deal

May 15, 2006 7:00 AM UTC

The university granted HaptoGuard exclusive worldwide rights to a family of glutathione peroxidase mimetics to treat cardiovascular and other inflammatory diseases. HaptoGuard is being acquired by Al...